POLI, GUIDO
 Distribuzione geografica
Continente #
EU - Europa 1.039
NA - Nord America 805
AS - Asia 328
AF - Africa 6
OC - Oceania 2
Totale 2.180
Nazione #
US - Stati Uniti d'America 801
SE - Svezia 575
SG - Singapore 216
RU - Federazione Russa 198
IT - Italia 109
CN - Cina 59
FI - Finlandia 54
IE - Irlanda 53
IN - India 34
DE - Germania 27
MY - Malesia 9
GB - Regno Unito 8
NL - Olanda 5
CA - Canada 4
FR - Francia 4
IR - Iran 4
UG - Uganda 4
AU - Australia 2
BE - Belgio 2
ES - Italia 2
HK - Hong Kong 2
IL - Israele 2
TR - Turchia 2
EE - Estonia 1
MA - Marocco 1
NG - Nigeria 1
RO - Romania 1
Totale 2.180
Città #
Lawrence 231
Princeton 231
Singapore 120
Ashburn 107
Helsinki 51
Dublin 50
Moscow 48
Shanghai 43
Milan 34
Pune 31
New York 30
Boardman 23
Dallas 19
Washington 18
Seattle 13
Los Angeles 10
Kuala Lumpur 9
Rome 7
Lissone 5
Borås 4
Kampala 4
Trigolo 4
West Jordan 4
Ballincollig 3
Lappeenranta 3
Las Vegas 3
Santa Clara 3
Seregno 3
Triggiano 3
Worksop 3
Biggleswade 2
Birmingham 2
Bologna 2
Brescia 2
Buffalo 2
Camponogara 2
Cattolica 2
Forlì 2
Ghent 2
Guangzhou 2
Hadera 2
Huddinge 2
Melbourne 2
Naaldwijk 2
Nuremberg 2
Parma 2
Rosarno 2
San Zenone degli Ezzelini 2
Shenzhen 2
Southwark 2
Toronto 2
Zanjan 2
Amsterdam 1
Ancona 1
Andover 1
Beijing 1
Belleville 1
Bonnyrigg 1
Bouray-sur-Juine 1
Casablanca 1
Castro Urdiales 1
Chandler 1
East Brunswick 1
Hanover 1
Henderson 1
Isfahan 1
Kumar 1
Leawood 1
Newark 1
Phoenix 1
Prato 1
Rimini 1
Rockville 1
Sacramento 1
Secaucus 1
Siena 1
Stockholm 1
Tampa 1
Tartu 1
Ternate 1
Turin 1
Vaprio d'Adda 1
Totale 1.191
Nome #
1,25-dihydroxyvitamin D3 upregulates functional CXCR4 human immunodeficiency virus type 1 coreceptors in U937 minus clones: NF-Kappa B-independent enhancement of viral replication 45
Origin and evolution of SARS-CoV-2 29
Biobanking for COVID-19 research 28
M1 polarization of human monocyte-derived macrophages restricts pre and postintegration steps of HIV-1 replication. 27
Zika Virus: a re-emerging pathogen with rapidly evolving public health implications 26
Vinegar and its active component acetic acid inhibit SARS-CoV-2 infection in vitro and ex vivo 24
5-Hydroxytyrosol inhibits HIV-1 replication in primary cells of the lower and upper female reproductive tract 21
An approach to HIV gene therapy by transduction of multifunctional retroviral vectors in primary human T Lymphocytes 20
Amino acid starvation induces reactivation of silenced transgenes and latent HIV-1 provirus via down-regulation of histone deacetylase 4 (HDAC4) 20
TRIM22. A multitasking antiviral factor 19
Association between the presence of CCR5-specific antibodies and long term non progression 18
Activating Killer Immunoglobulin Receptors and HLA-C: A successful combination providing HIV-1 control 17
Heparin Protects Human Neural Progenitor Cells from Zika Virus-Induced Cell Death While Preserving Their Differentiation into Mature Neuroglial Cells 16
Modulation of NBAS-Related Functions in the Early Response to SARS-CoV-2 Infection 16
A FAMILY OF SERINE PROTEASES EXPRESSED EXCLUSIVELY IN MYELO-MONOCYTIC CELLS SPECIFICALLY PROCESSES THE NUCLEAR FACTOR-KAPPA-B SUBUNIT P65 IN-VITRO AND MAY IMPAIR HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION IN THESE CELLS 16
ACTIVATED LYMPHOCYTES-B FROM HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS INDUCE VIRUS EXPRESSION IN INFECTED T-CELLS AND A PROMONOCYTIC CELL-LINE, U1 16
A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses 16
Highlights of the 9th edition of the Conference on HIV Persistence During Therapy, 10-13 December 2019, Miami, USA 16
A PLATELET-ACTIVATING-FACTOR ANTAGONIST, RP-55778, INHIBITS CYTOKINE-DEPENDENT INDUCTION OF HUMAN-IMMUNODEFICIENCY-VIRUS EXPRESSION IN CHRONICALLY INFECTED PROMONOCYTIC CELLS 15
Association Study of Common Genetic Variants and HIV-1 Acquisition in 6,300 Infected Cases and 7,200 Controls 15
Chronically infected T-cell lines become handy for a novel assay measuring the reservoir of replication-competent HIV-1 15
Human Monocyte-Derived Macrophages (MDM): Model 2 14
Three-year immune reconstitution in PI-sparing and PI-containing antiretroviral regimens in advanced HIV-1 disease 14
In vivo T lymphocyte origin of macrophage-tropic strains of HIV. Role of monocytes during in vitro isolation and in vivo infection. 14
Asymmetric HIV-1 co-receptor use and replication in CD4+ T lymphocytes 14
[Transitory increase of OKT4+ lymphocytes in the peripheral blood of patients with lymphadenopathy syndrome treated with beta-interferon]. FT Incremento transitorio dei linfociti OKT4+ in sangue periferico di pazienti affetti da LAS trattati con IFN-beta. 14
ALPHA-INTERFERON SUPPRESSES VIRION BUT NOT SOLUBLE HUMAN-IMMUNODEFICIENCY-VIRUS ANTIGEN PRODUCTION IN CHRONICALLY INFECTED T-LYMPHOCYTIC CELLS 14
Coronaviridae and SARS-associated coronavirus strain HSR1 14
A Community Study of SARS-CoV-2 Detection by RT-PCR in Saliva: A Reliable and Effective Method 13
Inhibition of intra- and extra-cellular Tat function and HIV expression by pertussis toxin B-oligomer 13
Preparing for phase II/III HIV vaccine trials in Africa 13
Broad spectrum inhibition of HIV-1 infection by sulfated K5 Escherichia coli polysaccharide derivatives 13
CYTOKINE-MEDIATED INDUCTION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) EXPRESSION AND CELL-DEATH IN CHRONICALLY INFECTED U1 CELLS - DO TUMOR-NECROSIS-FACTOR-ALPHA AND GAMMA-INTERFERON SELECTIVELY KILL HIV-INFECTED CELLS 13
Experiences in immune reconstitution. The rationale for interleukin-2 administration to HIV-infected individuals 13
Cytokines and soluble receptor changes in the transition from primary to early chronic HIV type 1 infection 13
Candidate Microbicide 5-hydroxytyrosol (5-HT) Inhibits Productive R5 HIV-1 Infection of Human Cervical Tissue Explants (CTE). 13
Engagement of CD30 shapes the secretion of cytokines by human gamma delta T cells 13
Retroviruses and opportunistic infections--eighth annual conference--structured therapy interruption. 13
Bacterial toxins: Potential weapons against HIV infection 13
The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells 13
Human CD34(+) cells express CXCR4 and its ligand stromal cell-derived factor-1. Implications for infection by T-cell tropic human immunodeficiency virus 13
Highlights from the 8th International Workshop on HIV Persistence during Therapy, 12-15 December 2017, Miami, FL, USA 13
Sex matters. cytokines and disease progression in men and women receiving combination antiretroviral therapy 12
Host Restriction Factors Modulating HIV Latency and Replication in Macrophages 12
Laureate ESCI award for excellence in clinical science 1999: cytokines and the human immunodeficiency virus: from bench to bedside 12
FP-21399 (Lexigen Pharmaceuticals). 12
Cytokine and chemokine based control of HIV infection and replication 12
PRO-140 (Progenics). 12
IMMUNOPATHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION 12
THE ROLE OF MONOCYTE MACROPHAGES AND CYTOKINES IN THE PATHOGENESIS OF HIV-INFECTION 12
M1 and M2a Polarization of Human Monocyte-Derived Macrophages Inhibits HIV-1 Replication by Distinct Mechanisms 12
A General Strategy to Endow Natural Fusion-protein-Derived Peptides with Potent Antiviral Activity 12
Impairment of in vitro natural antibacterial activity in HIV-infected patients 12
Amotosalen Photochemical Inactivation of Severe Acute Respiratory Syndrome CoronaVirus (SARS-CoV) in Human Platelet Concentrates 12
Vaccine adjuvants: A priority for vaccine research 12
Long-lasting CCR5 internalization by antibodies in a subset of long-term non progressors: a possible protective effect against disease progression 12
Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat 12
MCP-1 and CCR2 in HIV infection: Regulation of agonist and receptor expression 11
Shorter survival of SDF1-3 ' Al3 ' A homozygotes linked to CD4(+) T cell decrease in advanced human immunodeficiency virus type I infection 11
Defective nef alleles in a cohort of hemophiliacs with progressing and nonprogressing HIV-1 infection 11
Role of cytokines and chemokines in the regulation of innate immunity and HIV infection 11
Human T-cell leukemia virus type 2 induces survival and proliferation of CD34(+) TF-1 cells through activation of STAT1 and STAT5 by secretion of interferon-gamma and granulocyte macrophage-colony-stimulating factor 11
Restricted replication of non-syncytium-inducing HIV in Th1 and Th2 lymphocytes 11
Cytokine modulation of HIV expression. 11
Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. 11
T lymphocytes of HIV-positive individuals: preloaded guns in spite of highly active antiretroviral therapy? 11
NF-KAPPA-B-DEPENDENT AND NF-KAPPA-B-INDEPENDENT PATHWAYS OF HIV ACTIVATION IN A CHRONICALLY INFECTED T-CELL LINE 11
Mononuclear phagocytes and HIV infection 11
Ligand-engaged urokinase-type plasminogen activator receptor and activation of the CD11b/CD18 integrin inhibit late events of HIV expression in monocytic cells 11
The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT. 11
N-acetyl-cysteine is a potent suppressor of human immunodeficiency virus transcription in persistently infected cells. 11
The interferon-stimulated gene TRIM22: A double-edged sword in HIV-1 infection 11
Heparin Precursors with Reduced Anticoagulant Properties Retain Antiviral and Protective Effects That Potentiate the Efficacy of Sofosbuvir against Zika Virus Infection in Human Neural Progenitor Cells 10
The Long and Winding Road towards an HIV Cure 10
Modulation of endogenous IL-1 beta and IL-1 receptor antagonist results in opposing effects on HIV expression in chronically infected monocytic cells 10
The role of urokinase-type plasminogen activator (uPA)/uPA receptor in HIV-1 infection 10
Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells. 10
Rapid killing of actinomycin D-treated tumor cells by mononuclear phagocytes: characterization of effector cells in mice. 10
The rise and fall of intermittent interleukin-2 therapy in HIV infection 10
Inhibition of R5X4 dualtropic HIV-1 primary isolates by single chemokine co-receptor ligands 10
RECOMBINANT GP120 SPECIFICALLY ENHANCES TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION AND IG SECRETION IN LYMPHOCYTES-B FROM HIV-INFECTED INDIVIDUALS BUT NOT FROM SERONEGATIVE DONORS 10
Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms. 10
Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide 10
CYTOKINES IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME AND OTHER INFECTIOUS-DISEASES 10
Sulfated K5 Escherichia coli polysaccharide derivatives inhibit human immunodeficiency type-1 (HIV-1) infection: candidate microbicides to prevent sexual HIV transmission 10
Plastic restriction of HIV-1 replication in human macrophages derived from M1/M2 polarized monocytes 10
HIV-1-mediated insertional activation of STAT5B and BACH2 trigger viral reservoir in T regulatory cells 10
A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1 10
Interferon-inducible TRIM22 contributes to maintenance of HIV-1 proviral latency in T cell lines 10
U1 and OM10.1. Myeloid Cell Lines as Surrogate Models of Reversible Proviral Latency 9
Macrophage polarization and HIV-1 infection 9
CYTOKINE REGULATION OF ACUTE AND CHRONIC HIV-INFECTION IN-VITRO - FROM CELL-LINES TO PRIMARY MONONUCLEAR-CELLS 9
ULTRAVIOLET-IRRADIATION AND CYTOKINES AS REGULATORS OF HIV LATENCY AND EXPRESSION 9
Persistent replication of severe acute respiratory syndrome coronavirus in human tubular kidney cells selects for adaptive mutations in the membrane protein 9
Differential dynamics of Epstein-Barr virus in individuals infected with human immunodeficiency virus-1 receiving intermittent interleukin-2 and antiretroviral therapy 9
Impairment of polymorphonuclear leucocyte function in patients with acquired immunodeficiency syndrome and with lymphadenopathy syndrome 9
Selective inhibition of HIV replication in primary macrophages but not T lymphocytes by macrophage-derived chemokine 9
INTERLEUKIN-10 BLOCKS HIV REPLICATION IN MACROPHAGES BY INHIBITING THE AUTOCRINE LOOP OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-6 INDUCTION OF VIRUS 9
Pertussis toxin B-oligomer dissociates T cell activation and HIV replication in CD4 T cells released from infected lymphoid tissue 9
Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. 9
Totale 1.329
Categoria #
all - tutte 45.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.850


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 1 0 0
2020/20212 0 0 0 0 0 2 0 0 0 0 0 0
2021/2022110 0 0 0 59 16 3 4 5 1 3 3 16
2022/20231.179 544 237 95 8 10 108 56 57 25 4 30 5
2023/2024487 7 26 64 25 37 138 22 38 4 29 29 68
2024/2025427 388 39 0 0 0 0 0 0 0 0 0 0
Totale 2.243